Is Fresenius (FRE) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 51.6% / 30% | 7.8% / 30% | 13.3% / 30% | 0.53% / 5% | ✗ NOT HALAL |
| DJIM | 51.6% / 33% | 7.8% / 33% | 13.3% / 33% | 0.53% / 5% | ✗ NOT HALAL |
| MSCI | 31.2% / 33% | 4.7% / 33% | 8.0% / 33% | 0.53% / 5% | ✓ HALAL |
| S&P | 51.6% / 33% | 7.8% / 33% | 13.3% / 33% | 0.53% / 5% | ✗ NOT HALAL |
| FTSE | 31.2% / 33% | 4.7% / 33% | 8.0% / 50% | 0.53% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 24.9% | |
| Operating Margin | 10.8% | |
| Net Margin | 5.5% | |
| Return on Equity (ROE) | 8.0% | |
| Return on Assets (ROA) | 3.4% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $2.4B |
| Free Cash Flow | $1.5B |
| Total Debt | $13.6B |
| Debt-to-Equity | 60.4 |
| Current Ratio | 1.3 |
| Total Assets | $43.5B |
Price & Trading
| Last Close | EUR 44.06 |
| 50-Day MA | EUR 48.30 |
| 200-Day MA | EUR 46.89 |
| Avg Volume | 870K |
| Beta | 0.9 |
|
52-Week Range
EUR 31.60
| |
About Fresenius (FRE)
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fresenius Helios segments. The Fresenius Kabi segment offers products for therapy and care of critically and chronically ill patients, including biopharmaceuticals, clinical nutrition, MedTech products, intravenously administered generic drugs, and IV fluids. It also provides biosimilar drugs; enteral and parenteral nutrition products; and medical technologies that include disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment operates hospitals, medical care centers, occupational health centers, prevention centers, and outpatient health centers, as well as provision of medical diagnostics. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Fresenius (FRE) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Fresenius is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Fresenius's debt ratio?
Fresenius's debt ratio is 51.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 31.2%.
What are Fresenius's key financial metrics?
Fresenius has a market capitalization of $24.6B, trailing P/E ratio of 16.1, and revenue of $21.8B. The company maintains a gross margin of 24.9% and a net margin of 5.5%. Return on equity stands at 8.0%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.